Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Boston Beer Company Inc (SAM) vs Stryker Corporation (SYK) Price & Performance

Boston Beer Company IncTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Boston Beer Company Inc vs Stryker Corporation — how do they compare? Boston Beer Company Inc trades at $179.73 (market cap $1.86B), while Stryker Corporation trades at $347.43 (market cap $132.64B). The key difference: Stryker Corporation is far larger — about 71.3× Boston Beer Company Inc's market cap, and Stryker Corporation pays a 1.02% dividend while Boston Beer Company Inc pays none. Which is the better fit depends on your goals.

SAMSYK
Market Cap
$1.86B$132.64B
Sector
Consumer StaplesTechnology
52-Week High
$260.05$394.34
52-Week Low
$161.08$282.58
Enterprise Value
$1.63B$144.11B
Dividend Yield
1.02%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Boston Beer Company Inc

The Boston Beer Company (SAM) trades at $186.61, up 1.94% on the day, with a bullish technical signal driven by moving averages. The stock shows mixed fundamentals; while the P/E ratio of 22.66 and P/S of 0.99 suggest reasonable valuation, recent quarterly earnings have missed expectations, and the company faces volume declines in core brands. Positive cash flow and innovation in ready-to-drink products provide some offset. Analyst sentiment is cautious, with a consensus price target of $207.33 but a majority hold rating.

Outlook: Upside exists if new product growth accelerates and margins improve, but risks from weak demand and competitive pressure persist. The stock's trajectory hinges on reversing volume trends and achieving future earnings targets, making it a hold for now with watchful optimism.

Stryker Corporation

Stryker (SYK) trades at $339.03, up 0.47% on the day, with a bullish technical signal from moving averages. The company reported strong Q2 2026 results, beating EPS estimates with $3.69 versus $3.49 expected, and demonstrated robust 9% organic sales growth. Analyst consensus is strongly positive with a $379.44 price target and 74% buy ratings. Recent news highlights recovery from a cybersecurity incident and the launch of Mako RPS robotic technology.

The outlook remains favorable given earnings momentum and product innovation, though risks include competitive pressures and potential cyber disruptions. Valuation multiples such as a P/E of 35.84 suggest premium pricing, requiring sustained growth to justify. Institutional ownership trends show mixed activity, with some funds increasing stakes recently.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Boston Beer Company Inc

Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.

Read more on SAM

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK